These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 26010811)

  • 1. Structure-Activity Relationships of (+)-Naltrexone-Inspired Toll-like Receptor 4 (TLR4) Antagonists.
    Selfridge BR; Wang X; Zhang Y; Yin H; Grace PM; Watkins LR; Jacobson AE; Rice KC
    J Med Chem; 2015 Jun; 58(12):5038-52. PubMed ID: 26010811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological characterization of the opioid inactive isomers (+)-naltrexone and (+)-naloxone as antagonists of toll-like receptor 4.
    Wang X; Zhang Y; Peng Y; Hutchinson MR; Rice KC; Yin H; Watkins LR
    Br J Pharmacol; 2016 Mar; 173(5):856-69. PubMed ID: 26603732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereochemistry and innate immune recognition: (+)-norbinaltorphimine targets myeloid differentiation protein 2 and inhibits toll-like receptor 4 signaling.
    Zhang X; Peng Y; Grace PM; Metcalf MD; Kwilasz AJ; Wang Y; Zhang T; Wu S; Selfridge BR; Portoghese PS; Rice KC; Watkins LR; Hutchinson MR; Wang X
    FASEB J; 2019 Aug; 33(8):9577-9587. PubMed ID: 31162938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of enantiopure 10-nornaltrexones in the search for Toll-like receptor 4 antagonists and opioid ligands.
    Selfridge BR; Deschamps JR; Jacobson AE; Rice KC
    J Org Chem; 2014 Jun; 79(11):5007-18. PubMed ID: 24773391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the Function of (+)-Naltrexone Precursors: Their Activity as TLR4 Antagonists and Potential in Treating Morphine Addiction.
    Gao J; Lin C; Zhang C; Zhang X; Wang Y; Xu H; Zhang T; Li H; Wang H; Wang X
    J Med Chem; 2024 Feb; 67(4):3127-3143. PubMed ID: 38306598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissecting the Innate Immune Recognition of Opioid Inactive Isomer (+)-Naltrexone Derived Toll-like Receptor 4 (TLR4) Antagonists.
    Zhang X; Cui F; Chen H; Zhang T; Yang K; Wang Y; Jiang Z; Rice KC; Watkins LR; Hutchinson MR; Li Y; Peng Y; Wang X
    J Chem Inf Model; 2018 Apr; 58(4):816-825. PubMed ID: 29518316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4).
    Hutchinson MR; Zhang Y; Brown K; Coats BD; Shridhar M; Sholar PW; Patel SJ; Crysdale NY; Harrison JA; Maier SF; Rice KC; Watkins LR
    Eur J Neurosci; 2008 Jul; 28(1):20-9. PubMed ID: 18662331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mu opioid receptor activation modulates Toll like receptor 4 in murine macrophages.
    Franchi S; Moretti S; Castelli M; Lattuada D; Scavullo C; Panerai AE; Sacerdote P
    Brain Behav Immun; 2012 Mar; 26(3):480-8. PubMed ID: 22240038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental autoimmune encephalopathy (EAE)-induced hippocampal neuroinflammation and memory deficits are prevented with the non-opioid TLR2/TLR4 antagonist (+)-naltrexone.
    Kwilasz AJ; Todd LS; Duran-Malle JC; Schrama AEW; Mitten EH; Larson TA; Clements MA; Harris KM; Litwiler ST; Wang X; Van Dam AM; Maier SF; Rice KC; Watkins LR; Barrientos RM
    Behav Brain Res; 2021 Jan; 396():112896. PubMed ID: 32905811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A further assessment of a role for Toll-like receptor 4 in the reinforcing and reinstating effects of opioids.
    Yue K; Tanda G; Katz JL; Zanettini C
    Behav Pharmacol; 2020 Apr; 31(2&3):186-195. PubMed ID: 30741729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
    J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for a role of heat shock protein-90 in toll like receptor 4 mediated pain enhancement in rats.
    Hutchinson MR; Ramos KM; Loram LC; Wieseler J; Sholar PW; Kearney JJ; Lewis MT; Crysdale NY; Zhang Y; Harrison JA; Maier SF; Rice KC; Watkins LR
    Neuroscience; 2009 Dec; 164(4):1821-32. PubMed ID: 19788917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycoepoxydiene inhibits activation of BV2 microglia stimulated by lipopolysaccharide through suppressing NF-κB, ERK 1/2 and toll-like receptor pathways.
    Su X; Chen Q; Chen W; Chen T; Li W; Li Y; Dou X; Zhang Y; Shen Y; Wu H; Yu C
    Int Immunopharmacol; 2014 Mar; 19(1):88-93. PubMed ID: 24447679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmentation of spinal morphine analgesia and inhibition of tolerance by low doses of mu- and delta-opioid receptor antagonists.
    Abul-Husn NS; Sutak M; Milne B; Jhamandas K
    Br J Pharmacol; 2007 Jul; 151(6):877-87. PubMed ID: 17502848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of Toll-Like Receptors (TLR2, TLR4) Attenuates Pain and Potentiates Buprenorphine Analgesia in a Rat Neuropathic Pain Model.
    Jurga AM; Rojewska E; Piotrowska A; Makuch W; Pilat D; Przewlocka B; Mika J
    Neural Plast; 2016; 2016():5238730. PubMed ID: 26962463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly purified lipoteichoic acid induced pro-inflammatory signalling in primary culture of rat microglia through Toll-like receptor 2: selective potentiation of nitric oxide production by muramyl dipeptide.
    Kinsner A; Boveri M; Hareng L; Brown GC; Coecke S; Hartung T; Bal-Price A
    J Neurochem; 2006 Oct; 99(2):596-607. PubMed ID: 16879708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of N-isobutylnoroxymorphone from naltrexone by a selective cyclopropane ring opening reaction.
    Fujii H; Osa Y; Ishihara M; Hanamura S; Nemoto T; Nakajima M; Hasebe K; Mochizuki H; Nagase H
    Bioorg Med Chem Lett; 2008 Sep; 18(18):4978-81. PubMed ID: 18755589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological characterization of noroxymorphone as a new opioid for spinal analgesia.
    Lemberg KK; Siiskonen AO; Kontinen VK; Yli-Kauhaluoma JT; Kalso EA
    Anesth Analg; 2008 Feb; 106(2):463-70, table of contents. PubMed ID: 18227301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-inflammatory effects of genistein via suppression of the toll-like receptor 4-mediated signaling pathway in lipopolysaccharide-stimulated BV2 microglia.
    Jeong JW; Lee HH; Han MH; Kim GY; Kim WJ; Choi YH
    Chem Biol Interact; 2014 Apr; 212():30-9. PubMed ID: 24491678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonists of toll like receptor 4 maybe a new strategy to counteract opioid-induced hyperalgesia and opioid tolerance.
    Li Q
    Med Hypotheses; 2012 Dec; 79(6):754-6. PubMed ID: 23062774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.